Withus Pharmaceutical Co Ltd banner
W

Withus Pharmaceutical Co Ltd
KOSDAQ:330350

Watchlist Manager
Withus Pharmaceutical Co Ltd
KOSDAQ:330350
Watchlist
Price: 8 230 KRW 1.48% Market Closed
Market Cap: ₩108.6B

Withus Pharmaceutical Co Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Withus Pharmaceutical Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
W
Withus Pharmaceutical Co Ltd
KOSDAQ:330350
Research & Development
-₩2.6B
CAGR 3-Years
-7%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Research & Development
-₩198.2B
CAGR 3-Years
-23%
CAGR 5-Years
-7%
CAGR 10-Years
-18%
SK Biopharmaceuticals Co Ltd
KRX:326030
Research & Development
-₩169.7B
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Research & Development
-₩195.8B
CAGR 3-Years
-8%
CAGR 5-Years
2%
CAGR 10-Years
-2%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Research & Development
-₩8.7B
CAGR 3-Years
-8%
CAGR 5-Years
17%
CAGR 10-Years
-9%
C
Caregen Co Ltd
KOSDAQ:214370
Research & Development
-₩5.7B
CAGR 3-Years
3%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
No Stocks Found

Withus Pharmaceutical Co Ltd
Glance View

Market Cap
108.6B KRW
Industry
Pharmaceuticals

Withus Pharmaceutical Co., Ltd. manufactures and sells prescription drugs. The company is headquartered in Seoul, Seoul and currently employs 217 full-time employees. The company went IPO on 2020-07-03. The firm's main products include circulatory agents, musculoskeletal agents, digestive agents, antibiotics and other prescription drugs. And the Company is engaged in contract manufacturing operation(CMO).

Withus Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show

See Also

What is Withus Pharmaceutical Co Ltd's Research & Development?
Research & Development
-2.6B KRW

Based on the financial report for Sep 30, 2025, Withus Pharmaceutical Co Ltd's Research & Development amounts to -2.6B KRW.

What is Withus Pharmaceutical Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-32%

Over the last year, the Research & Development growth was -17%. The average annual Research & Development growth rates for Withus Pharmaceutical Co Ltd have been -7% over the past three years , -32% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett